University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Stanton A. Glantz, PhD

Stanton A. Glantz, PhD

Professor, Department of Medicine; and Director, Center for Tobacco Control Research and Education, UCSF; Co-Leader, Tobacco Control Program, UCSF Helen Diller Family Comprehensive Cancer Center
American Legacy Foundation Distinguished Professorship in Tobacco Control, UCSF

Cancer Center Program Memberships

Tobacco Control

Research Summary

I am a widely recognized researcher with a reputation for identifying and pursuing high-impact questions that make practical contributions to tobacco control policy development, evaluation, and implementation. I am skilled in both qualitative and quantitative research methods, having written several books on tobacco control policy and two successful statistics textbooks. As Director of the UCSF Center for Tobacco Control Research and Education (CTCRE), I have extensive practical experience in developing and managing transdisciplinary academic programs and bringing together faculty from many disciplines. I have supervised a total of 96 fellows and graduate students during my career and am the Program Director of the CTCRE Postdoctoral Training Program in collaboration with Dr. Pamela Ling. I have published in a broad range of tobacco control areas, including economic models of the effects of tobacco control policies on health outcomes and health care costs, social and environmental determinants of smoking and smoking cessation, young adult smoking, and health effects of secondhand smoke, particularly on heart disease. I wrote the first papers based on analyses of previously secret tobacco industry documents (published in JAMA in 1995). Since then, I have worked with the UCSF Library to build the Legacy Tobacco Documents Library, which now exceeds 83 million pages (and is growing). The library is a major international research resource that has supported preparation of over 900 publications, including 134 authored by me, and the CTCRE is an internationally known training resource for tobacco document research that serves postdoctoral fellows and many others working in tobacco control. I am also the Principal Investigator of the UCSF Tobacco Center of Regulatory Science (TCORS), which brings together a broad multidisciplinary group of faculty and provides training opportunities and funds for pilot studies for trainees with an interest in tobacco regulatory science.

Education

University of Cincinnati, OH, BS, 1969, Aerospace Engineering
Stanford University, CA, MS, 1970, Applied Mechanics
Stanford University, CA, PhD, 1973, Applied Mechanics and Engineering Economic Systems
Stanford University, CA, Postdoc, 1975, Cardiology
University of California San Francisco, CA, Postdoc, 1977, Cardiovascular Research


Professional Experience

  • 1965-68
    Student trainee, NASA Manned Spacecraft Center, Houston
  • 1969
    Aerospace Engineer, NASA Manned Spacecraft Center, Houston, TX
  • 1977-80
    Assistant Professor of Medicine in Residence, Univ. of California, San Francisco
  • 1981-82
    Associate Professor of Medicine in Residence, Univ. of California, San Francisco
  • 1983-87
    Associate Professor of Medicine, Univ. of California, San Francisco
  • 1987-present
    Professor of Medicine, Univ. of California, San Francisco
  • 2002-present
    Director, UCSF Center for Tobacco Control Research and Education

Honors & Awards

  • (1960)
    Eagle Scout, Bronze Palm
  • (1964)
    Outstanding future teacher
  • (1964)
    Bausch and Lomb Science Award
  • (1968)
    Tau Beta Pi (engineering)
  • (1969-72)
    NSF Graduate Fellowship
  • (1975-77)
    Bay Area Heart Research Committee Senior Research Fellowship
  • (1977-82)
    NIH Research Career Development Award
  • (1978)
    Best Paper Published in Computer
  • (1986)
    Janssen Lecture of Society for Cardiac Anesthesia
  • (1992)
    Fellow, American College of Cardiology
  • (1992-1997)
    Associate Editor, Journal of the American College of Cardiology
  • (1996)
    James Madison Freedom of Information Award, Society of Professional Journalists
  • (1996)
    Alton Ochsner Award of Special Recognition
  • (1997)
    UCSF Chancellor's Award for Public Service
  • (1998)
    American Society of Addiction Medicine Annual Award
  • (1998)
    Gleitsman Foundation Citizen Activist Award
  • (1999)

    American Heart Association Rashkind Lecture
  • (1999)
    "Taking the Heat" Award, University of California Tobacco Related Diseases Research Program
  • (2000)
    Ralph R. Sachs Lecture, UCLA
  • (2000)
    Common Cause Public Service Achievement Award
  • (2000)
    Robert Wood Johnson Innovators in Substance Abuse Control
  • (2002)
    FAMRI Cahan Distinguished Professor Award
  • (2003)
    American Public Health Association, Alcohol and Other Drugs section Lifetime Achievement Award
  • (2005)
    Elected to Institute of Medicine

Selected Publications

  1. Apollonio DE, Glantz S. Tobacco manufacturer lobbying to undercut minimum price laws: an analysis of internal industry documents. Tob Control. 2020 Jan 22.
    View on PubMed
  2. Lightwood J, Anderson S, Glantz SA. Predictive validation and forecasts of short-term changes in healthcare expenditure associated with changes in smoking behavior in the United States. PLoS One. 2020; 15(1):e0227493.
    View on PubMed
  3. Nguyen KH, Glantz SA, Palmer CN, Schmidt LA. Transferring Racial/Ethnic Marketing Strategies From Tobacco to Food Corporations: Philip Morris and Kraft General Foods. Am J Public Health. 2020 Jan 16; e1-e8.
    View on PubMed
  4. Yadav A, Ling P, Glantz S. Smokeless tobacco industry's brand stretching in India. Tob Control. 2020 Jan 09.
    View on PubMed
  5. Psotka MA, Rushakoff J, Glantz SA, De Marco T, Fleischmann KE. The Association Between Secondhand Smoke Exposure and Survival for Patients With Heart Failure. J Card Fail. 2020 Jan 09.
    View on PubMed
  6. Glantz SA. Net Effect of Young Adult Dual Combusted Cigarette and E-Cigarette Users' Anticipated Responses to Hypothetical E-Cigarette Marketing Restrictions. Subst Use Misuse. 2020 Jan 06; 1-3.
    View on PubMed
  7. Bhatta DN, Glantz SA. Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis. Am J Prev Med. 2020 Feb; 58(2):182-190.
    View on PubMed
  8. Tynan MA, Polansky JR, Driscoll D, Garcia C, Glantz SA. Tobacco Use in Top-Grossing Movies - United States, 2010-2018. MMWR Morb Mortal Wkly Rep. 2019 Nov 01; 68(43):974-978.
    View on PubMed
  9. Orenstein DG, Glantz SA. The Grassroots of Grass: Cannabis Legalization Ballot Initiative Campaign Contributions and Outcomes, 2004-2016. J Health Polit Policy Law. 2019 Oct 15.
    View on PubMed
  10. Alzahrani T, Glantz SA. Adding Data From 2015 Strengthens the Association Between E-Cigarette Use and Myocardial Infarction. Am J Prev Med. 2019 Oct; 57(4):569-571.
    View on PubMed
  11. Bhatta DN, Bialous S, Crosbie E, Glantz S. Exceeding FCTC obligations: Nepal overcoming tobacco industry interference to enact a comprehensive tobacco control policy. Nicotine Tob Res. 2019 Sep 19.
    View on PubMed
  12. Hafez AY, Gonzalez M, Kulik MC, Vijayaraghavan M, Glantz SA. Uneven Access to Smoke-Free Laws and Policies and Its Effect on Health Equity in the United States: 2000-2019. Am J Public Health. 2019 Nov; 109(11):1568-1575.
    View on PubMed
  13. Kearns CE, Glantz SA, Apollonio DE. In defense of sugar: a critical analysis of rhetorical strategies used in The Sugar Association's award-winning 1976 public relations campaign. BMC Public Health. 2019 Aug 22; 19(1):1150.
    View on PubMed
  14. Bhatta D, Crosbie E, Bialous S, Glantz S. Tobacco control in Nepal during a time of government turmoil (1960-2006). Tob Control. 2019 Jul 30.
    View on PubMed
  15. Egbe CO, Bialous SA, Glantz S. Framework Convention on Tobacco Control Implementation in Nigeria: Lessons for Low- and Middle-Income Countries. Nicotine Tob Res. 2019 07 17; 21(8):1122-1130.
    View on PubMed
  16. Lempert LK, Glantz SA. Tobacco Industry Promotional Strategies Targeting American Indians/Alaska Natives and Exploiting Tribal Sovereignty. Nicotine Tob Res. 2019 06 21; 21(7):940-948.
    View on PubMed
  17. Yang YT, Glantz S. San Francisco Voters End the Sale of Flavored Tobacco Products. Ann Intern Med. 2019 06 18; 170(12):907-908.
    View on PubMed
  18. Bowling C, Glantz SA. Civic Engagement in California Cannabis Policy Development. J Psychoactive Drugs. 2019 Nov-Dec; 51(5):391-399.
    View on PubMed
  19. Bhatta DN, Glantz SA. Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health. J Am Heart Assoc. 2019 Jun 18; 8(12):e012317.
    View on PubMed
  20. Apollonio DE, Glantz SA. Tobacco industry promotions and pricing after tax increases: An analysis of internal industry documents. Nicotine Tob Res. 2019 May 06.
    View on PubMed

Go to UCSF Profiles, powered by CTSI